Giovanni Maria Iannantuono

6PUBLICATIONS
12CO-AUTHORS
Natural language processingGlycoconjugatesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 28, 2023
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives.

Stefano Sganga, Silvia Riondino, Giovanni Maria Iannantuono

|Jan 21, 2023
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma.

Rosa Maria Paragliola, Francesco Torino, Agnese Barnabei

|Dec 29, 2022
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series.

Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga

|Aug 12, 2022
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Giovanni Maria Iannantuono, Francesco Torino, Roberto Rosenfeld

|Apr 12, 2022
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.

Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga

Pageof 1